Related by context. All words. (Click for frequent words.) 71 nucleoside reverse transcriptase inhibitor 69 Raltegravir 68 nucleoside analog 68 Sustiva efavirenz 68 nucleotide analogue 68 Abacavir 68 investigational integrase inhibitor 68 CCR5 antagonist 67 reverse transcriptase inhibitors 67 Alfacell proprietary ribonuclease 67 Atripla combines 67 transcriptase inhibitors NNRTIs 67 chimeric monoclonal antibody 66 liposomal formulation 66 zidovudine AZT 66 Dalbavancin 66 lamivudine zidovudine 66 AZT 3TC 66 quinolone 66 Thiovir 66 vapreotide acetate 65 Maribavir 65 tenofovir Viread 65 leukotriene receptor antagonist 65 glycopeptide 65 intranasal formulation 65 Elvitegravir 65 non nucleoside inhibitor 65 nucleoside analogue 65 oral renin inhibitor 65 protein tyrosine phosphatase 1B 65 Pharmacokinetics PK 65 vinca alkaloid 65 Voreloxin 65 CCR5 antagonists 65 tetracycline antibiotic 65 combination antiretroviral therapy 65 Mg Uk 65 5 HT3 antagonist 64 beta lactam antibiotic 64 indinavir 64 calcitonin gene related 64 generation purine nucleoside 64 Nucleoside 64 polymerase inhibitor 64 RNA antagonists 64 NS5B polymerase 64 inhibit replication 64 Talabostat 64 Nitazoxanide 64 benzimidazole 64 NRTI 64 IMiDs ® 64 Hsp# Inhibitor 64 Bosutinib 64 lipopeptides 64 AZT zidovudine 64 nucleotide analog 64 hypereosinophilic syndrome 64 Ganciclovir 64 FUSILEV enhances 64 beta lactamase inhibitor 64 atazanavir Reyataz 64 CYT# potent vascular disrupting 64 non peptidic protease 64 somatostatin analogue 64 selective antagonist 64 boosted protease inhibitor 64 highly selective inhibitor 64 paclitaxel Taxol 64 DermaVir 64 Piperacillin 64 tegafur 64 Methicillin 64 artemisinin derivative 64 Orally administered 64 Belerofon 63 transcriptase inhibitor NNRTI 63 Viread tenofovir disoproxil fumarate 63 orally administered inhibitor 63 nucleoside analogues 63 Etravirine 63 nucleotide reverse transcriptase 63 protease inhibitor PI 63 proteasome inhibitors 63 ADP receptor antagonist 63 sodium glucose cotransporter 63 meropenem 63 SGLT2 inhibitors 63 ganciclovir 63 anionic backbone 63 nucleoside reverse transcriptase inhibitors 63 CYP#A# CYP#D# 63 Clindamycin 63 IMiDs R 63 orally dosed 63 proteasome inhibitor 63 NRTI resistance 63 cidofovir 63 neuraminidase inhibitor 63 non nucleoside 63 NS#/#A protease 63 AZT zidovudine Retrovir 63 Anidulafungin 63 targeted antifolate 63 Humanized Anti 63 prescribed proton pump 63 Protease inhibitors 63 echinocandins 63 brand ciclesonide HFA 63 Nilotinib 63 Mg Usa 63 lipoglycopeptide 63 kanamycin 63 vinorelbine tartrate 63 HepDirect prodrug 63 poliovirus vaccine 63 HCV NS5B polymerase 63 Inactivated 63 Integrase Inhibitor 63 miconazole Lauriad ® 63 Liposomal 62 siRNA binds 62 nelfinavir 62 nucleotide analogs 62 cytidine nucleoside analog 62 IMiDs ® compound 62 oral prodrug 62 2 methoxyestradiol 62 Adenoviral 62 beta lactams 62 Maraviroc 62 cyclin dependent kinase inhibitor 62 Macrolide 62 novel emulsion formulation 62 Conjugate 62 signal transduction inhibitor 62 Recombinant Human 62 PEGylated anti 62 long acting muscarinic 62 histone deacetylase HDAC inhibitors 62 pan HDAC inhibitor 62 oxacillin 62 Blinatumomab 62 CCR5 inhibitor 62 ritonavir boosted protease inhibitor 62 plasmid encoding 62 Zerit 62 selective orally bioavailable 62 TLR9 agonist 62 Protease Inhibitors 62 discontinued Viread 62 direct renin inhibitor 62 Protease Inhibitor 62 non thiazolidinedione TZD 62 Dasatinib 62 Methylnaltrexone 62 Vicriviroc 62 selectively inhibits 62 topical gel formulation 62 Lubiprostone 62 Entry Inhibitor 62 rifamycins 62 PNP inhibitor 62 orally bioavailable 62 imatinib Gleevec ® 62 Pimavanserin 62 thiazolides 62 Gilead Viread 62 tazobactam 62 3TC lamivudine 62 integrase inhibitor 62 DNA intercalator 62 factor Xa 62 fusion inhibitors 62 alkylating agent 62 nonnucleoside reverse transcriptase inhibitors 62 echinocandin 62 HMG CoA reductase inhibitors 62 Cefixime 62 triggers apoptosis programmed 62 small molecule tyrosine 62 ZOLINZA 62 Deforolimus 62 NNRTIs 62 non nucleoside reverse 62 peripherally acting 62 Lenalidomide 62 Dapagliflozin 62 accumulate preferentially 62 Cytarabine 62 Adjuvanted 62 flavopiridol 62 maturation inhibitor 62 transcriptase inhibitors 62 recombinant subunit vaccine 62 Temsirolimus 62 Erlotinib 62 antiinfectives called 62 cholesteryl ester transfer 62 prostanoid 62 ergot derivatives 62 HCV RNA polymerase 62 gets USFDA nod 62 valganciclovir 62 PDE4 inhibitor 62 nelfinavir Viracept 62 Naive Patients 62 TNF Tumor Necrosis Factor 62 dasatinib Sprycel 62 tenofovir disoproxil fumarate Viread 61 AAG geldanamycin analog 61 Lopinavir 61 semisynthetic 61 Fluvastatin 61 Vidaza ® 61 immune modulating 61 demethylation agents 61 erlotinib Tarceva ® 61 Haemophilus b Conjugate 61 lipid nanoparticle 61 Xanafide 61 Interferons 61 Albuferon TM 61 pentamidine 61 stavudine d4T 61 receptor tyrosine kinase inhibitor 61 Bevirimat 61 non porcine pancreatic 61 integrase inhibitors 61 Clavulanate 61 recombinant adeno associated 61 Safinamide 61 sorafenib tablets 61 Dabigatran etexilate 61 dasatinib Sprycel ® 61 bazedoxifene selective estrogen receptor 61 Locked Nucleic Acid LNA 61 Vidaza R 61 reversible inhibitors 61 mTOR inhibitor 61 selective inhibitor 61 delipidation 61 infliximab Remicade 61 EPIVIR 61 broad spectrum cephalosporin 61 envelope glycoprotein 61 replicon 61 BAL# [002] 61 Fluticasone 61 delta gamma agonist 61 itraconazole Sporanox 61 Imatinib mesylate 61 immunotoxin 61 Fidaxomicin 61 adalimumab Humira 61 mecamylamine 61 LymphoStat B belimumab 61 SPL# Gel vaginal microbicide 61 potent inducer 61 CDDO Im 61 MVA BN R 61 Valproic acid 61 GW# [003] 61 #mg/#mg 61 enzyme inhibitor 61 ethambutol 61 Ixabepilone 61 herpes simplex viruses 61 anti CD3 61 efavirenz Sustiva 61 Tyrima 61 Peginterferon 61 Bruton tyrosine kinase 61 triciribine phosphate monohydrate 61 Adefovir 61 NEUGENE 61 SGLT 2 61 beta2 agonist 61 Bucindolol 61 Pegloticase 61 histone deacetylase HDAC inhibitor 61 dihydrofolate reductase 61 Investigational Oral 61 capsular polysaccharide 61 Factor Receptor 61 albumin bound paclitaxel 61 IAP inhibitor 61 YONDELIS 61 beta lactam 61 Zorbtive TM 61 varicella zoster virus VZV 61 aspirin clopidogrel 61 inhibitor PPI 61 daptomycin 61 methicillin susceptible Staphylococcus aureus 61 opioid receptor antagonist 61 Epratuzumab 61 Receptor Agonist 61 Xeloda ® 61 IRDye 61 Linaclotide 61 sorafenib Nexavar 61 NXL# 61 sulfonamide 61 reuptake inhibitor 61 Granulocyte Colony Stimulating Factor 61 Gleevec resistant 61 FOLFOX6 chemotherapy regimen 61 Lisofylline 60 Cytomegalovirus CMV 60 DFMO 60 Platelet Derived Growth 60 NS5b 60 Respiratory Virus 60 Protease 60 Denufosol 60 Daptomycin 60 highly selective endothelin 60 idarubicin 60 catalytic antioxidant compounds 60 AEG# 60 immunotherapeutic agent 60 Squalamine 60 pioglitazone HCl 60 AdVac ® 60 rifamycin 60 Rigel R# 60 l lysine 60 insulin sensitizers 60 essential thrombocythemia ET 60 sulindac 60 immune modulators 60 stavudine lamivudine 60 R Saizen R 60 Oncolytic 60 novel immunomodulatory 60 SPRYCEL ® 60 purified protein 60 direct thrombin inhibitors 60 Chemokine Receptor 60 macrolide antibiotic 60 selective agonist 60 docetaxel Taxotere ® 60 immunomodulatory therapy 60 CYP#A# isoenzyme 60 Olaparib 60 inhibits protein synthesis 60 Doripenem 60 Epstein Barr virus EBV 60 NRTI backbone 60 emtricitabine FTC 60 5 HT2A serotonin 60 quinolone antibiotic 60 lipopeptide 60 Levaquin levofloxacin 60 Lymphocytic 60 dihydrochloride 60 Kinase Inhibitor 60 novel prodrug 60 immune modulatory 60 fusion inhibitor 60 HIV integrase inhibitor 60 serogroup B 60 HIV treatments Reyataz 60 Teriflunomide 60 Aliskiren 60 Interferon alpha 60 small molecule thrombopoietin 60 Transdrug R 60 thalidomide Thalomid 60 CYP#A# substrate 60 VivaGel ™ 60 evaluating tivozanib 60 darunavir Prezista 60 Investigational eFlow Nebulizer System 60 Fc fusion protein 60 rHuPH# recombinant human 60 CCR5 receptor antagonist 60 ketolide antibiotic 60 Posaconazole 60 injectable investigational 60 Achieves Primary Endpoint 60 surface antigen HBsAg 60 agonists antagonists 60 targeting PCSK9 60 Vidofludimus 60 potently inhibit 60 humanized therapeutic 60 novel topoisomerase 60 Bavituximab 60 aminoglycosides 60 administered subcutaneously 60 Upregulation 60 immunomodulator 60 Novel Oral 60 Vidaza azacitidine 60 Amgen Neulasta R 60 histone deacetylase inhibitor 60 Meets Primary Endpoint 60 plasmid DNA pDNA 60 selectively inhibited 60 Syndrome HARS 60 prophylactic vaccine 60 small molecule glucokinase 60 Emtriva Viread 60 MTP inhibitor 60 Interferon beta 1a 60 plus prednisone prednisolone 60 MAGE A3 ASCI 60 inactivated influenza 60 DHFR 60 sulfamethoxazole 60 Drug Candidate 60 Tezampanel 60 selective modulator 60 potent topoisomerase II 60 signal transduction inhibitors 60 humanised monoclonal antibody 60 Tumor Necrosis Factor 60 histone deacetylase inhibitors 60 Pathway Inhibitor 60 Enkephalin 60 etanercept Enbrel 60 Ustekinumab 60 Angiotensin Converting Enzyme 60 Epivir R 60 Epivir 60 investigational oral inhibitor 60 Conjugate Vaccine 60 primaquine 60 azoles 60 Plasmid DNA 60 emtricitabine Emtriva 60 bortezomib Velcade 60 containing abacavir 60 pan histone deacetylase 60 therapies ACTs 60 developing Bicifadine serotonin 60 albiglutide 60 targeted radiotherapeutic 60 COPEGUS R 60 selective kinase inhibitor 60 MEK inhibitors 60 humanized monoclonal 60 transgenic rats 60 aripiprazole Abilify 60 pretreatment serum 59 HCV polymerase 59 oropharyngeal candidiasis OPC 59 nucleoside analogs 59 peripherally restricted 59 platinum chemotherapeutic 59 CG# [003] 59 nucleoside 59 myelofibrosis polycythemia vera 59 Pertuzumab 59 deoxy 59 Orally Active 59 virosome 59 Monoclonal antibody 59 candidate DB# 59 M2 subunit 59 bexarotene 59 PI3K/mTOR 59 5 HT2A inverse 59 HCV replicon 59 SGLT Inhibitors 59 nanomolar 59 reslizumab 59 antiangiogenic agent 59 anti secretory 59 M1 muscarinic 59 agent VDA 59 Tasimelteon 59 Selzentry maraviroc 59 AKT inhibitor 59 lopinavir ritonavir Kaletra 59 recurrent genital herpes 59 Cancer Incidence Mortality 59 chlamydial 59 peptide CGRP 59 cathepsin K inhibitor 59 reverse vaccinology 59 tyrosine kinase inhibitor TKI 59 immunostimulatory 59 GV# [001] 59 HDAC Inhibitor 59 IAP inhibitors 59 fosbretabulin 59 Shows Promise Against 59 Vandetanib 59 negative allosteric modulator 59 murine model 59 tyrosine kinase inhibitor 59 Aurora Kinase 59 ALN TTR 59 Reclast zoledronic acid 59 reversible inhibitor 59 Hepatitis B Virus 59 HGS ETR1 mapatumumab 59 bendamustine ifosfamide 59 CD8 + cytotoxic 59 antimitotic 59 Topoisomerase II 59 Zolinza 59 Didanosine 59 synthetic peptides 59 HCV Hepatitis C 59 Extensively drug 59 Polymerase Inhibitor 59 Fingolimod 59 Protein Kinase C 59 dihydrofolate reductase DHFR 59 toenail onychomycosis 59 BMS # 59 lamivudine stavudine 59 Human immunodeficiency virus 59 deacetylase 59 attenuated strain 59 #HT# 59 Laquinimod 59 receptor inhibitor 59 MVA BN ® 59 included exfoliative dermatitis 59 protozoal 59 Isentress raltegravir 59 Cloretazine VNP#M 59 thrombin receptor 59 neuro inflammatory 59 transcriptase inhibitor 59 glycoprotein GP IIb IIIa 59 Bruton tyrosine kinase Btk 59 antibiotic azithromycin 59 5 Fluorouracil 59 induces antibodies 59 Vytorin combines 59 Cyclosporine 59 bleomycin 59 naturally occurring molecule 59 oral antiviral 59 Cytotoxicity 59 serotonin norepinephrine reuptake inhibitor 59 Selective Inhibitor 59 small molecule inhibitor 59 SinuNase TM 59 Oral Fingolimod 59 pneumococci 59 Vaccine Adjuvant 59 griseofulvin 59 attach auristatin 59 aprepitant 59 Cytotoxic 59 amantadine Symmetrel 59 Cyclosert TM 59 virus HBV 59 Pazopanib 59 FDA APPROVES 59 Initiates Phase II 59 selective inhibition 59 CTAP# Capsules 59 antagonist LAMA 59 norfloxacin 59 pyrimidines 59 pyrimidine nucleoside analog 59 monoclonal antibody MAb 59 Fludase 59 tissue transglutaminase 59 pyrimethamine 59 sapacitabine CYC# 59 virologically suppressed 59 immune modulator 59 rxRNA 59 visilizumab 59 nucleosides 59 renin inhibitor 59 cephalosporin antibiotics 59 Vitrasert R 59 selective adenosine 59 HuLuc# 59 Conjugated 59 Retinoic Acid 59 Pruvel TM 59 histone deacetylase HDAC 59 oral talactoferrin 59 geldanamycin 59 angiotensin receptor blocker ARB 59 virus HCV protease inhibitor 59 cytidine 59 SCH # 59 virus AAV 59 ® lenalidomide 59 Roflumilast 59 oxazolidinone 59 Cardiotoxicity 59 bifunctional 59 type glutamate receptor 59 Cloretazine 59 Plavix clopidogrel bisulfate 59 Azacitidine 59 pathophysiological effects 59 CpG ODNs 59 world safest multivalent 59 intravenously administered 59 investigational protease inhibitor 59 nanopharmaceutical 59 Aflibercept 59 HuMax HepC 59 Crizotinib 58 mediated inhibition 58 thymidylate synthase 58 ImmunoVEX 58 Darusentan 58 selective adhesion molecule 58 DG# compounds targeting 58 elvitegravir 58 Protease inhibitor 58 Fulvestrant 58 Smac mimetics 58 Intravenous Human 58 bile acid sequestrant 58 gonadotropin releasing hormone GnRH 58 antifolates 58 Darinaparsin 58 Belimumab 58 Onconase 58 potently inhibits 58 advanced metastatic renal 58 Novel Compound 58 PI3K/Akt pathway inhibitor 58 MetroGel 58 vaccine serotypes 58 Lenocta TM sodium stibogluconate 58 TLR agonists 58 erlotinib Tarceva 58 oncolytic 58 Receptor Antagonist 58 small molecule Hedgehog 58 Warfarin Coumadin 58 Levoleucovorin 58 BRSV 58 Complicated Skin 58 drugs tenofovir lamivudine 58 Poly ICLC 58 HBeAg negative 58 4 PDE4 enzyme 58 sodium sulfate sodium chloride 58 systemic RNAi therapeutic 58 Aptivus ® 58 dipeptidyl peptidase 4 58 amoxicillin penicillin 58 Vaginal gel 58 Streptococcus pneumonia 58 epigenetic therapies 58 vascular disrupting agent 58 humanized antibody 58 Aptamer 58 thromboxane A2 58 K#N 58 amikacin 58 Nelfinavir 58 davalintide 58 Carvedilol 58 Glucagon Like Peptide 58 TRIM5a 58 CDK inhibitor 58 introduced NEUGENE 58 protein mTOR 58 interstitial cystitis IC 58 enkephalin 58 epothilone 58 Oncogenic 58 non nucleoside HCV 58 metaglidasen 58 muscarinic antagonist 58 FS Antihemophilic Factor Recombinant 58 oral rivaroxaban 58 mineralocorticoid receptor 58 PPI omeprazole 58 Fenretinide 58 Submits IND 58 liposomal delivery 58 investigational humanized monoclonal antibody 58 Presents Preclinical Data 58 VZV 58 Receives Orphan Drug Designation 58 Bortezomib 58 Sapacitabine 58 Interferon gamma 58 polymerase inhibitors 58 endothelin receptor antagonists 58 HepaGam B 58 fluoroquinolone class 58 Ticagrelor 58 Completes Patient Enrollment 58 HGS# 58 aldehyde dehydrogenase ALDH2 deficiency 58 oral dihydropyrimidine dehydrogenase DPD 58 Boceprevir 58 Zoraxel TM 58 retaspimycin hydrochloride 58 Curaxin CBLC# 58 PRN FDA Approves 58 hygienic cleansing 58 Lixisenatide 58 retinoid 58 acetylcholinesterase AChE 58 NS4A 58 neurokinin 1 58 beta 1a 58 NS3 protease 58 5 FU leucovorin 58 synthetic retinoid 58 receptor modulators 58 IMA# 58 demethylating agent 58 Files IND 58 oral transmucosal 58 cortisol synthesis 58 receptor modulator 58 chemokine receptor 58 adamantanes 58 hyperphenylalaninemia HPA due 58 Aviptadil 58 Sitagliptin 58 selectively binds 58 ADAMTS# 58 ND# [002] 58 N methyl 58 5 HT4 58 LPA1 receptor 58 nitric oxide donating prostaglandin 58 multidrug 58 IMPDH inhibitor 58 PARI Pharma GmbH 58 Visceral leishmaniasis 58 monocyte chemotactic protein 58 SSc 58 radezolid 58 Interferon beta 58 BLyS specific 58 Factor Xa inhibitor 58 CRTH2 58 Enzastaurin 58 assay detects 58 novel VDA molecule 58 Prolongs Survival 58 Ramelteon 58 receptor blocker 58 Monoclonal Antibody 58 alpha agonists 58 palonosetron 58 Darapladib 58 kidney urologic 58 antiandrogen 58 Vectical 58 Guanilib 58 Hepatitis C Virus HCV 58 oral ghrelin agonist 58 Submits NDA 58 Investigational Treatment 58 inhibits Akt activation 58 SIX RO ROG 58 Hepatitis B HBV 58 targeting CD# 58 ART# 58 CFTR corrector 58 potentiator 58 protein CETP 58 RNAi Therapeutic 58 JAK2 inhibitor 58 VEGF inhibitors 58 TO AVOID PREGNANCY WHILE 58 entacapone 58 SERMs 58 proprietary polysaccharide 58 avidin 58 Amino acid 58 TBC M4 58 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 58 monovalent vaccine 58 tubulin inhibitors 58 inverse agonist 58 novel synthetic peptide 58 HCV protease inhibitors 58 Pim kinases 58 Cyclosert 58 TLR8 agonist 58 conjugate vaccine 58 Anthrax Toxin 58 PENNVAX ™ B 58 MKC# MKC# PP 58 Vaccine Candidate 58 endothelin receptor 58 F. tularensis 58 antibiofilm 58 Peptide YY 58 Photodynamic therapy PDT 58 THR beta agonist 58 Romiplostim 58 Silodosin 58 multi kinase inhibitor 58 TAFA# 58 lapatinib Tykerb 58 laropiprant 58 Hydralazine 58 Miconazole 58 Demonstrates Significant 58 corticosteroid dexamethasone 58 hepatoma 58 Bleomycin 58 5 HT6 receptor 58 cyclic peptide 58 NRTIs 58 LHRH agonists 58 MOG #-# 58 NNRTI 58 PEGylated Fab fragment 58 immunotoxins 58 cyclophosphamide methotrexate 57 humanized monoclonal antibody 57 Preclinical studies suggest 57 Archexin 57 DNA methyltransferase inhibitors 57 oral dual endothelin 57 Single Dose 57 folate analogue metabolic 57 IGF1R 57 topical microbicide 57 Muraglitazar 57 purified inactivated vaccine 57 endothelin antagonist 57 ancrod 57 Epstein Barr Virus EBV 57 chemically modified siRNA 57 ALK inhibitor 57 Janus kinase 57 protease enzyme 57 TLR7 agonist 57 xanthine oxidase inhibitor 57 Rimantadine 57 Fluorouracil 57 gamma secretase inhibitor 57 cetuximab Erbitux R 57 BCG refractory carcinoma 57 metformin sulfonylureas 57 nanoviricides 57 taxane derivative 57 Dendritic Cells 57 Launches Generic Version 57 Exemestane 57 EGFR tyrosine kinase inhibitor 57 Candida infection 57 5 HT3 receptor 57 Therapy HAART 57 arginine vasopressin AVP 57 CCR5 tropic 57 ramipril Altace 57 Tekmira SNALP stable 57 monoclonal antibody mAb 57 nilotinib Tasigna ® 57 platform HDL Mimetic 57 DepoVax 57 amphotericin 57 adeno associated viruses 57 matrix metalloproteases 57 molecular chaperone regulator 57 protease inhibitor 57 docetaxel Taxotere R 57 tumor xenograft models 57 Epothilones 57 Long acting beta2 57 Ecallantide 57 mu opioid receptor antagonist 57 selective estrogen receptor 57 Vitro Activity 57 Afatinib 57 Tegretol carbamazepine 57 gastro intestinal inflammation 57 Systemic lupus erythematosus SLE 57 topical antifungal 57 TLK# 57 HCV protease 57 neuronal nicotinic receptor NNR 57 PKC# 57 inhibitor RG# 57 cetuximab Erbitux ® 57 antidiabetic drugs 57 Human papillomavirus HPV 57 Carfilzomib 57 Starlix 57 DGAT 57 HCV protease inhibitor 57 Gefitinib 57 HIV reverse transcriptase 57 Protein Interactions 57 mycobacterium tuberculosis 57 isotypes 57 humanized monoclonal antibodies 57 ospemifene 57 Terbinafine 57 inflammatory PDE 57 5HT 57 Hycamtin ® 57 Neugene 57 adrenal steroid hormones 57 tumor vascular disrupting 57 γ secretase 57 TRC# 57 fluticasone furoate 57 Recombinant interferon alpha 57 systemic fungal infections 57 suppressive therapy 57 HTS assay 57 selective A2A adenosine receptor 57 Sindbis virus 57 Factor VIIa 57 IV bolus formulation 57 VA# [002] 57 artemisinins 57 MKC# MT 57 HDACi 57 Ribavirin causes 57 Antithrombin 57 statin simvastatin 57 Personalized Immunotherapy 57 Qdot 57 beta lactamases 57 psoralen 57 ocular formulation 57 TÎ ² 4 57 mda 7 57 herpes zoster shingles 57 volociximab 57 Fondaparinux 57 Announces Tentative Approval 57 siRNAs targeting 57 #HT#A 57 bevacizumab Avastin R 57 oxidative stress inducer 57 outer membrane proteins 57 therapeutic monoclonal antibody 57 toxoids 57 Epidermal Growth Factor Receptor 57 Losartan 57 investigational oral 57 antiapoptotic 57 acyclovir Zovirax 57 Telmisartan 57 dSLIM 57 Bafetinib 57 sulfonylhydrazine class 57 enzyme reverse transcriptase 57 nilotinib Tasigna 57 peptidic compound 57 enterococcal 57 apoptosis inducers 57 Immunomodulatory 57 GVAX ® 57 Tesetaxel 57 inhibit viral replication 57 Vitrasert ® 57 Oracea TM 57 antibiotic ampicillin 57 Adjuvant Treatment 57 alpha interferon 57 cyclooxygenase COX 57 Traficet EN 57 antibody mediated 57 VRX# [002] 57 rivastigmine Exelon 57 aurora kinase 57 Zovirax acyclovir 57 #mg ATC 57 RoACTEMRA 57 Romidepsin 57 Respiratory Syncytial Virus RSV 57 anti angiogenic agent 57 Human papillomavirus 57 gatifloxacin 57 Atrasentan 57 inhaled formulation 57 Initiates Enrollment 57 azelaic acid 57 ImmunoGen TAP technology 57 Patients Treated With 57 gp# protein [002] 57 humanized anti 57 parainfluenza virus 57 HCV replication 57 First Patient Dosed 57 neomycin 57 subcutaneous formulation 57 Previously Untreated 57 5 lipoxygenase activating 57 BAY #-# 57 regorafenib 57 Tofacitinib 57 CCR5 mAb